Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
NCT01434797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2020-03-31
Summary
The study hypothesis is that F-18-FDG PET/CT and microcalorimetry might have a diagnostic value in the detection of permanent central venous catheters (PCVC) infection when conventional means of PCVC infection detection are non-conclusive.
Conditions
Sponsors & Collaborators
-
University of Lausanne Hospitals
lead OTHER
Principal Investigators
-
John O Prior, PhD MD · Centre Hospitalier Universitaire Vaudois and University of Lausanne
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2014-11-30
- Completion
- 2020-03-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB
NCT02972697 ·Status: UNKNOWN ·Phase: PHASE1
-
18F-AmBF3-TATE PET/CT for Imaging NET Patients
NCT04207762 ·Status: COMPLETED
-
Comparison of FDG PET and Bone Scintigraphy/Labelled Leukocyte/Gallium Scintigraphy in Diabetic Foot Osteomyelitis
NCT03712046 ·Status: TERMINATED ·Phase: NA
-
Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19
NCT04764721 ·Status: COMPLETED ·Phase: NA
-
Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation
NCT00835783 ·Status: TERMINATED
-
FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis
NCT00590395 ·Status: COMPLETED ·Phase: NA
-
Benefits Study of Respiratory-gated PET Acquisition in Lung Disease
NCT01812031 ·Status: COMPLETED ·Phase: NA
-
Assessment of Investigational Positron Emission Tomography and Post-Processing Procedures Performed as Add-ons to Standard of Care Imaging
NCT03490812 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET Imaging of Inflammation and Lipid Lowering Study
NCT04073797 ·Status: RECRUITING ·Phase: NA
-
18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection
NCT02450942 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection
NCT01764919 ·Status: TERMINATED ·Phase: PHASE2
-
Positron Emission Tomography of Infection and Vasculitis
NCT01878721 ·Status: COMPLETED
-
18F-FDG Tomography and Labeled Leukocyte Scintigraphy
NCT05994768 ·Status: COMPLETED
-
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
NCT01421953 ·Status: COMPLETED ·Phase: NA
-
FDG-PET Imaging in Complicated Diabetic Foot
NCT00194298 ·Status: ACTIVE_NOT_RECRUITING
-
PET/MRI Perfusion and CT Perfusion in Solid Tumors
NCT02314962 ·Status: TERMINATED
-
Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein
NCT00964275 ·Status: COMPLETED ·Phase: NA
-
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
NCT00201942 ·Status: COMPLETED ·Phase: PHASE3
-
Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis
NCT05762172 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis
NCT04156230 ·Status: COMPLETED ·Phase: PHASE2
-
Patterns and Prevalence of FDG Extravasation in PET/CT Scans
NCT03041090 ·Status: COMPLETED ·Phase: NA
-
Predictive Value of PET CT in the Histologic Lymph Node Status of Patients With Squamous Cell Carcinoma of the Oral N0 Clinical and Radiological Cavity.
NCT03947892 ·Status: UNKNOWN
-
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949 ·Status: RECRUITING ·Phase: NA
-
Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism
NCT01107327 ·Status: COMPLETED
-
Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients
NCT01834469 ·Status: COMPLETED ·Phase: PHASE1/PHASE2